Evidence map›Paper›PMID 39787608›Full record

SynthesisEuropean heart journal. Cardiovascular Imaging2025

Prognostic value of myocardial computed tomography-derived extracellular volume in severe aortic stenosis requiring aortic valve replacement: a systematic review and meta-analysis.

Andrea Faggiano, Elisa Gherbesi, Stefano Carugo, Matteo Brusamolino, Dan Alexandru Cozac, Elena Cozza, Maria Teresa Savo, Francesco Cannata, Marco Guglielmo, Lucia La Mura and 12 more

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in European heart journal. Cardiovascular Imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Extracellular volume fraction by cardiac computed tomography (ECVEuropean heart journal. Imaging methods and practice · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Andrea FaggianoDepartment of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.ORCID 0000-0002-3247-3203
Elisa GherbesiDepartment of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Stefano CarugoDepartment of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Matteo BrusamolinoDepartment of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.ORCID 0000-0003-2077-2879
Dan Alexandru CozacCardiology Clinic, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Elena CozzaCardiology Clinic, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Maria Teresa SavoCardiology Clinic, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Francesco CannataDepartment of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Via C. Parea 4, 20138 Milan, Italy.
Marco GuglielmoDivision of Heart and Lungs, Department of Cardiology, Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands.
Lucia La MuraDepartment of Advanced Biomedical Sciences, University Federico II of Naples, Naples, Italy.
Fabio FazzariDepartment of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Via C. Parea 4, 20138 Milan, Italy.
Nazario CarrabbaDepartment of Cardiothoracovascular Medicine, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.ORCID 0000-0002-5190-5227
Edoardo ConteDepartment of Clinical Cardiology and Cardiovascular Imaging, Galeazzi-Sant'Ambrogio Hospital IRCCS, Milan, Italy.ORCID 0000-0003-1443-5788
Saima MushtaqDepartment of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Via C. Parea 4, 20138 Milan, Italy.
Andrea BaggianoDepartment of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Via C. Parea 4, 20138 Milan, Italy.
Andrea Igoren GuaricciUniversity Cardiology Unit, Interdisciplinary Department of Medicine, University of Bari Aldo Moro, Bari, Italy.ORCID 0000-0001-7133-4401
Roberto PedrinelliCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy.
Ciro IndolfiIstituto di Cardiologia, Dipartimento di Scienze Mediche e Chirurgiche, Università degli Studi 'Magna Graecia', Catanzaro, Italy.
Gianfranco SinagraCardiology Specialty School, University of Trieste, Trieste, Italy.
Pasquale Perrone FilardiDepartment of Advanced Biomedical Sciences, University Federico II of Naples, Naples, Italy.
Valeria PergolaCardiology Clinic, Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova, Padova, Italy.
Gianluca PontoneDepartment of Perioperative Cardiology and Cardiovascular Imaging, Centro Cardiologico Monzino IRCCS, Via C. Parea 4, 20138 Milan, Italy.ORCID 0000-0002-1339-6679

Funding

Fondazione Regionale per la Ricerca Biomedica 3432721
6 · The paper itself

Abstract

Computed tomography (CT)-derived extracellular volume (ECV) fraction is a non-invasive method to quantify myocardial fibrosis. Evaluating CT-ECV during aortic valve replacement (AVR) planning CT in severe aortic stenosis (AS) may aid prognostic stratification. This meta-analysis evaluated the prognostic significance of CT-ECV in severe AS necessitating AVR. Electronic database searches of PubMed, Ovid MEDLINE, and Cochrane Library were performed. The primary outcome was to compare the occurrence of a composite of cardiovascular outcomes in patients with severe AS undergoing AVR with elevated myocardial CT-ECV values vs. patients with normal values. Secondary outcomes included all-cause mortality and heart failure (HF)-related hospitalization. A total of 1223 patients undergoing AVR for severe AS were included in 10 studies: 524 patients with high values of CT-ECV and 699 with normal values of CT-ECV. The pooled CT-ECV cut-off to define elevated values and predict prognosis was 30.7% [95% confidence interval (CI): 28.5-33.7%]. At a mean follow-up of 17.9 ± 2.3 months after AVR, patients with elevated CT-ECV experienced a significantly higher number of cardiovascular events [43.4 vs. 14.0%; odds ratio (OR): 4.3, 95% CI: 3.192-5.764, P < 0.001]. Regarding secondary outcomes, all-cause mortality occurred in 29.3% of patients with elevated CT-ECV vs. 11.6% with CT-ECV below the cut-off (OR: 3.5, 95% CI: 2.276-5.311, P < 0.001), whereas HF hospitalization was observed in 25.5% vs. 5.9% (OR: 4.9, 95% CI: 2.283-10.376, P < 0.001). Patients undergoing AVR for severe AS with elevated CT-ECV values experience a worse post-intervention prognosis. The implementation of CT-ECV evaluation in routine AVR planning protocols should be considered.

Indexed as

Aortic Valve StenosisHeart Valve Prosthesis ImplantationTomography, X-Ray ComputedAgedFemaleHumansMalePrognosisRisk AssessmentSeverity of Illness Indexaortic stenosisaortic valve replacementcardiac computed tomography angiographycomputed tomography–derived extracellular volume fraction

Identifiers

PMID39787608
PMCPMC11879236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.